Patent intelligence · US
US 11291728
Anhydrous sodium thiosulfate and formulations thereof
Anhydrous sodium thiosulfate and formulations thereof
Patent details — US 11291728
- Jurisdiction
- US
- Status
- granted
- Grant date
- Apr 5, 2022
- Expiration
- Mar 31, 2042
- Applicant
- Fennec Pharmaceuticals, Inc.
- Claims
- 9
- CPC classes
- A61K, A61K33/04, A61K33/243, A61K47/02
Quick answer
US 11291728 (Anhydrous sodium thiosulfate and formulations thereof) is held by Fennec Pharmaceuticals, Inc.. Status: granted. Granted Apr 5, 2022. Expires Mar 31, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Fennec Pharmaceuticals, Inc.
- Grant date
- Expiration
- Claims
- 9
- CPC classes
- A61K, A61K33/04, A61K33/243, A61K47/02, A61K47/18, A61K47/183
More from Fennec Pharmaceuticals, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12311026
Therapeutic uses for sodium thiosulfate formulations
granted -
US 11998604
Therapeutic uses for sodium thiosulfate formulations
granted -
US 11992530
Therapeutic uses for sodium thiosulfate and formulations
granted -
US 11964018
Therapeutic uses for sodium thiosulfate formulations
granted -
US 11617793
Anhydrous sodium thiosulfate and formulations thereof
granted -
US 11510984
Anhydrous sodium thiosulfate and formulations thereof
granted -
US 10792363
Anhydrous sodium thiosulfate and formulations thereof
granted
Frequently asked questions
What is US patent 11291728?
US 11291728 (Anhydrous sodium thiosulfate and formulations thereof) is held by Fennec Pharmaceuticals, Inc.. Status: granted. Granted Apr 5, 2022. Expires Mar 31, 2042 (16 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 11291728?
Fennec Pharmaceuticals, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 8 pharmaceutical patents for this assignee.
When does US 11291728 expire?
Our index shows an expiration date of Mar 31, 2042 (16 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.